GERCOR. Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients - Andre, T; Quinaux, E; Louvet, C (Journal of Clinical Oncology, 2005)
(Suppl 16): Abstract 3522